Alimera Sciences’ $27 Million Investment

Olshan Frome Wolosky represented Velan Capital in the transaction.Velan Capital co-led an investment in a $12 million PIPE consisting of Series B preferred stock and warrants…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here